TuesdayJan 24, 2023 10:30 am

QualityStocksNewsBreaks – CubCrafters Inc. Has Changed the Face of Backcountry Aviation

CubCrafters, the leading designer and manufacturer of light-sport, experimental and Part 23 certified backcountry aircraft, is guided by superior quality, industry-leading innovation and independent thinking. “CubCrafters has changed the face of backcountry aviation by producing and selling seven innovative models of light aircraft. Segmented into three categories – Light Sport Aircraft (‘LSA’), Experimental Builder Assist (‘E/AB’), and Part 23 certified aircraft – the models include the Carbon Cub SS, Carbon Cub FX-2, Carbon Cub FX-3, Carbon Cub EX-2, Carbon Cub EX-3, NXCub, and XCub,” reads a recent article. In 2022, the company achieved several milestones including welcoming outside investment for…

Continue Reading

TuesdayJan 24, 2023 10:30 am

Luxury Bed & Bath Product Designer Coyuchi Inc. Notes Reg A+ Successes and Goals for 2023, in Bell2Bell Podcast

Renewable textile innovator Coyuchi Inc. is dedicated to making luxury sustainable practice products a central part of the home living design industry Coyuchi’s President and CEO Eileen Mockus recently participated in a Bell2Bell podcast interview to discuss company achievements during 2022 and plans for 2023 Coyuchi to introduce two new products in 2023 that will use cotton the company helped grow last year through a California farm focused on soil biodiversity and renewable practices The company’s Reg A+ investment offering, that was announced in August, already topped $1 million milestone in December Organic luxury bed, bath, and apparel product innovator…

Continue Reading

TuesdayJan 24, 2023 10:04 am

QualityStocksNewsBreaks – Jupiter Wellness Inc. (NASDAQ: JUPW) Closes on $4.1M Direct, Private Placement Offerings

Jupiter Wellness (NASDAQ: JUPW), a wellness company focused on hair, skin and sexual wellness, has closed on its previously announced registered direct offering and concurrent private placement. The offering includes the purchase and sale of 4,315,787 shares in a registered direct offering, with the concurrent private placement calling for JUPW to issue and sell a total of 8,631,574 warrants to the same investors. The warrants are to purchase up to one share of common stock each at an exercise price of $1 per share. According to the announcement, the private placement warrants will be exercisable six months after issuance. The…

Continue Reading

TuesdayJan 24, 2023 9:45 am

Homes Leading Cause of Climate Crisis, GeoSolar Technologies Inc. at Forefront of Home Electrification Trend

Homes contribute significantly to climate change, producing twice as much carbon dioxide emissions annually than automobiles GeoSolar Technologies’ SmartGreen(TM) Home system utilizes leading edge solar, geothermal and air filtration technology to offer true net zero homes that achieve some of the highest HERS index ratings in the industry The company recently published a webinar discussing the industry while providing comprehensive insight on SmartGreen(TM) homes, from financial to health When it comes to greenhouse gases and carbon emissions that are polluting our atmosphere and contributing to climate change, cars are usually pointed at as the major culprit. That’s not an accurate…

Continue Reading

TuesdayJan 24, 2023 9:00 am

HeartBeam Inc. (NASDAQ: BEAT) Combats Rising Heart Disease Numbers by Leading Out in Heart-Attack Detection Space

Rates of cardiovascular risk factors, disease and heart attacks projected to increase significantly HeartBeam offers a personal, portable and easy-to-use heart-attack detection solution “Our HeartBeam AIMI and HeartBeam AIMIGo solutions will transform the way patients and doctors detect heart attacks,” states CEO With heart disease consistently being the leading cause of death in the United States (https://ibn.fm/kDLwz), companies such as HeartBeam (NASDAQ: BEAT) that are focusing on solutions are gaining both attention and support. As a cardiac technology company, HeartBeam is leading the way in identifying heart attacks by developing a personal, portable and easy-to-use heart-attack detection solution. HeartBeam’s efforts…

Continue Reading

MondayJan 23, 2023 1:24 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Pharmaceutical Expert as New Strategic Advisor

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has a new strategic advisor. The company announced that Julian Gangolli, the former president of GW Pharmaceuticals USA, has joined Lexaria as a strategic advisor. During his time at GW Pharmaceuticals, Gangolli managed US Food and Drug Administration approval of Epidiolex(R), the only pure cannabidiol (“CBD”) drug ever approved by the agency; he also oversaw the commercialization of the drug in the United States, which ultimately led to Jazz Pharmaceuticals acquiring GW Pharmaceuticals in a $7.2 billion transaction. In addition to his work at GW Pharmaceuticals, Gangolli served as North…

Continue Reading

MondayJan 23, 2023 1:07 pm

QualityStocksNewsBreaks – Jupiter Wellness Inc.’s (NASDAQ: JUPW) Redeemable Digital Coupons Now Available for Shareholders of Record

Jupiter Wellness (NASDAQ: JUPW), a company focused on hair, skin and sexual wellness, today announced availability of its redeemable digital coupons for shareholders of record to claim on Upstream’s trading app. Upon successful claim, shareholders may redeem the digital coupon for a gift package of company products valued at over $179 or trade with others globally on Upstream to bring new potential customers into the community. The announcement reads, “By incorporating Upstream’s Web3 digital coupons into our strategy, we aim to provide our shareholders with first-hand experience of our products and bring new potential customers into our community to drive…

Continue Reading

MondayJan 23, 2023 12:58 pm

QualityStocksNewsBreaks – QSAM Biosciences Inc. (QSAM) to Present at Emerging Growth Conference

QSAM Biosciences (OTCQB: QSAM) is developing next-generation therapeutic radiopharmaceuticals, including Samarium-153-DOTMP (CycloSam(R)), for the treatment of bone cancer and related diseases and conditions. The company today announced that it has been invited to present at the Emerging Growth Conference at 10:15 a.m. ET on Wednesday, Jan. 25, 2023. Leading QSAM’s presentation will be the company’s CEO Douglas Baum and other executive officers, who may subsequently open the floor for questions. Interested parties should visit https://ibn.fm/P2xIR to register to attend the conference and receive any updates. An archived webcast will be made available on EmergingGrowth.com and on the Emerging Growth YouTube…

Continue Reading

MondayJan 23, 2023 12:45 pm

CubCrafters Inc. Acquires Summit Aircraft Skis and Celebrates Contract Extension with US Government

CubCrafters has acquired Summit Aircraft Skis, including the company's design and manufacturing assets, unique patents, and related intellectual property The US Department of Agriculture Wildlife Service recently selected CubCrafters' flagship FAA-certified CC19 XCub for a new government aircraft-fleet-modernization contract CubCrafters is now offering investment opportunities through a Regulation A+ offering – managed through Manhattan Street Capital CubCrafters, a producer of best-in-class Backcountry Aircraft, announced its acquisition of Summit Aircraft Skis, including the company's design and manufacturing assets, unique patents, and related intellectual property, from the Summit Aircraft Corporation of Sandpoint, Idaho, last month. Its unique design allows pilots to quickly…

Continue Reading

MondayJan 23, 2023 12:00 pm

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Developing Innovative Inhaled NanoAb Therapeutics for Multiple Indications, Including COVID-19

Current monoclonal antibody therapies less effective against emerging COVID-19 variants BiondVax is developing an inhaled nanosized antibody (NanoAb) therapy for COVID-19 with human clinical Phase 1/2a results anticipated in 2023 The global monoclonal antibodies market was valued at $185.5 billion in 2021 and is projected to grow at a CAGR of 11.3% due to the rising prevalence of chronic diseases and demand for biologics The biologics market size was valued at $366.5 billion in 2021 and is expected to reach $719.94 billion by 2030 According to a new study, new COVID-19 subvariants have become dominant in recent months, rendering some…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered